UCFA
RDY icon

United Capital Financial Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

United Capital Financial Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361K Sell
24,898
-1,918
-7% -$25.9K ﹤0.01% 1283
2026
Q1 		$371K Buy
26,816
+5,878
+28% +$81.8K ﹤0.01% 1222
2025
Q4 		$294K Buy
20,938
+4,210
+25% +$59.1K ﹤0.01% 1177
2025
Q3 		$234K Sell
16,728
-512
-3% -$7.37K ﹤0.01% 1103
2025
Q2 		$259K Buy
17,240
+2,025
+13% +$28.9K ﹤0.01% 972
2025
Q1 		$201K Buy
15,215
+601
+4% +$8.29K ﹤0.01% 1018
2024
Q4 		$231K Buy
14,614
+149
+1% +$2.24K ﹤0.01% 975
2024
Q3 		$230K Buy
+14,465
New +$233K ﹤0.01% 962
2021
Q1 		– Sell
-97,980
Closed -$1.4M – 1228
2020
Q4 		$1.4M Sell
97,980
-22,745
-19% -$306K 0.01% 588
2020
Q3 		$1.68M Buy
+120,725
New +$1.44M 0.01% 543
2018
Q1 		– Sell
-286,045
Closed -$2.15M – 1352
2017
Q4 		$2.15M Buy
286,045
+2,945
+1% +$21.2K 0.02% 570
2017
Q3 		$2.02M Buy
283,100
+29,515
+12% +$212K 0.02% 569
2017
Q2 		$2.14M Sell
253,585
-12,250
-5% -$99.6K 0.02% 552
2017
Q1 		$2.13M Buy
265,835
+29,815
+13% +$257K 0.02% 551
2016
Q4 		$2.14M Buy
236,020
+10,610
+5% +$98.7K 0.02% 553
2016
Q3 		$2.09M Buy
+225,410
New +$2.15M 0.02% 574
2016
Q1 		– Sell
-291,030
Closed -$2.69M – 1264
2015
Q4 		$2.69M Buy
291,030
+204,485
+236% +$2.24M 0.03% 487
2015
Q3 		$1.11M Hold
86,545
– – 0.01% 663
2015
Q2 		$958K Buy
86,545
+920
+1% +$10.2K 0.01% 729
2015
Q1 		$890K Hold
85,625
– – 0.01% 748
2014
Q4 		$864K Buy
85,625
+175
+0.2% +$1.84K 0.01% 686
2014
Q3 		$898K Hold
85,450
– – 0.02% 632
2014
Q2 		$737K Buy
85,450
+9,480
+12% +$79.7K 0.01% 618
2014
Q1 		$667K Buy
+75,970
New +$661K 0.01% 577

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

United Capital Financial Advisors's RDY Position: Q2 2026 in Review

United Capital Financial Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 7.2% in Q2 2026, selling an estimated $25.9K and leaving 24,898 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #1283.

United Capital Financial Advisors first reported a position in RDY in Q1 2014 and has held it in 24 quarters since. The position peaked at $2.69M in Q4 2015. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • United Capital Financial Advisors held 24,898 shares of Dr. Reddy's Laboratories worth $361K as of Q2 2026.
  • United Capital Financial Advisors sold 1,918 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $25.9K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of United Capital Financial Advisors's portfolio in Q2 2026, its #1283 holding.
  • United Capital Financial Advisors first reported a position in Dr. Reddy's Laboratories in Q1 2014 and has held it in 24 quarters since.
  • United Capital Financial Advisors's Dr. Reddy's Laboratories position peaked at $2.69M in Q4 2015.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.